AbbVie Inc. (NYSE:ABBV)

CAPS Rating: 4 out of 5

ABBV News and Commentary

Caps

How do you think ABBV will perform against the market?

Add Stock to CAPS Watchlist

All Players

415 Outperform
11 Underperform
 

All-Star Players

90 Outperform
4 Underperform
 

Wall Street

8 Outperform
0 Underperform
 

Top ABBV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bdbcalm (< 20)
Submitted February 15, 2015

Sold off due to patent cliff concerns and Hep C drug discounts. I believe this is an overreaction and the stock will recover. There is more in the pipeline than the P/E - 13 - would imply.

TMFSpiffyPop (99.72)
Submitted January 09, 2015

This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More

ABBV VS S&P 500 (SPY)

Fools bullish on ABBV are also bullish on:

Fools bearish on ABBV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ABBV.

Recs

0
Member Avatar TMFFishBiz (39.11) Submitted: 9/29/2017 9:03:23 AM : Outperform Start Price: $88.08 ABBV Score: +7.36

Strong pipeline, great dividend, fast-growing cancer drug Imbruvica, and the company should be able to largely protect sales for Humira.

Recs

0
Member Avatar ATrain (59.10) Submitted: 8/31/2017 11:00:34 AM : Outperform Start Price: $73.99 ABBV Score: +26.81

Steady revenue growth and dividend increases. Industry has a significant Moat.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/3/2017 1:55:55 PM : Outperform Start Price: $61.78 ABBV Score: +48.83

Slightly undervalued pharma giant about to start inching higher?

Leaderboard

Find the members with the highest scoring picks in ABBV.

Score Leader

armydave

armydave (68.24) Score: +167.63

The Score Leader is the player with the highest score across all their picks in ABBV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
armydave 68.24 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
cooleyly 66.23 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. mattmmurphy 63.86 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
GW1000 95.99 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. valari25 99.60 1/10/2013 10/26/2015 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
drjohn432 < 20 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
concealedweaponR 39.98 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
deliman723 64.44 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
pirotta < 20 1/10/2013 Outperform 5Y $28.21 +241.96% +74.33% +167.63 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. kinosternon 99.52 1/9/2013 Outperform 5Y $28.34 +240.41% +75.13% +165.28 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCitigroup 93.22 2/23/2016 Outperform NS $52.29 +84.51% +31.85% +52.66 0 Comment
TrackDeutscheSec 88.23 10/21/2014 Outperform NS $49.75 +93.93% +33.45% +60.48 0 Comment
trackguggenheim < 20 10/2/2014 Outperform NS $51.41 +87.68% +31.73% +55.95 0 Comment
TrackBarclaysCap 91.76 7/2/2014 Outperform NS $50.76 +90.06% +29.81% +60.25 0 Comment
TrackGoldmanSach 76.57 12/3/2013 Outperform NS $42.81 +125.35% +42.15% +83.20 0 Comment
TrackBMOCapital < 20 10/28/2013 Outperform NS $42.81 +125.35% +45.43% +79.92 0 Comment
TrackArgus 91.24 8/12/2013 Outperform NS $38.62 +149.82% +51.84% +97.98 0 Comment
TrackJimCramer 84.91 6/10/2013 Outperform 3W $37.59 +156.63% +55.21% +101.42 0 Comment
TrackCreditSuiss 91.75 2/7/2013 Underperform NS $34.70 +100.33% +37.54% -62.79 12/5/2014 @ $69.52 0 Comment
TrackJimCramer 84.91 1/15/2013 Underperform 3W $34.28 +28.11% +12.06% -16.05 6/10/2013 @ $43.92 0 Comment

Featured Broker Partners